There is significant concern that current corticosteroid dosing may result in inadequate modulation of IL-6 and IL-10 levels and subsequent treatment failure or in toxicity from steroid-induced hyperglycemia or infection risk [7,33,34]. The gene discussed is IL6; the disease is infection.